Mark Reynolds
About Mark Reynolds
Mark Reynolds serves as the Director of Strategic Operations at Option Care Health, where he has worked since 2019. He has extensive experience in financial management and operational strategy, having previously held key positions at BioScrip, Inc., Home Infusion Solutions, and ExpertPlan.
Current Role at Option Care Health
Mark Reynolds serves as the Director of Strategic Operations at Option Care Health, a position he has held since 2019. He operates out of Swedesboro, New Jersey, where he is responsible for overseeing strategic initiatives within the organization. His role involves enhancing operational efficiency and implementing strategies that align with the company's goals.
Previous Experience at BioScrip, Inc.
Before joining Option Care Health, Mark Reynolds worked at BioScrip, Inc. as the Director of Strategic Operations from 2016 to 2019. During his tenure in Hammonton, New Jersey, he focused on operational strategies that contributed to the company's growth and efficiency.
Career Background in Finance and Operations
Mark Reynolds has a diverse background in finance and operations. He held various positions, including Director of Accounting at Home Infusion Solutions, LLC from 2014 to 2016, and Chief Financial Officer at ExpertPlan for a brief period in 2012. His experience also includes roles at Ascensus and ExpertPlan, where he contributed to financial management and operational improvements.
Educational Background in Accounting
Mark Reynolds studied at Trenton State College, now known as The College of New Jersey, where he earned a Bachelor of Science (B.S.) degree in Accounting from 1987 to 1991. His educational foundation has supported his extensive career in finance and strategic operations.
Notable Achievements in Operations
Throughout his career, Mark Reynolds has implemented significant operational improvements. He designed a digital imaging solution that saved $35,000 annually and streamlined the month-end close process by reducing it from over 30 days to just 5 days. Additionally, he played a key role in the global rollout of Hyperion Enterprise consolidation software for a company with over $250 million in revenue.